tetano
Editor, Senior Moderator
Curr Opin Virol
. 2021 Jul 24;50:49-58.
doi: 10.1016/j.coviro.2021.07.004. Online ahead of print.
Proteases and variants: context matters for SARS-CoV-2 entry assays
Christian S Stevens[SUP] 1 [/SUP], Kasopefoluwa Y Oguntuyo[SUP] 1 [/SUP], Benhur Lee[SUP] 2 [/SUP]
Affiliations
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), like other coronaviruses, relies on a flexible array of entry mechanisms, driven by the spike (S) protein. Entry is dependent on proteolytic priming, activation, and receptor binding; all of which can be variable, dependent on context. Here we review the implications of the complexity of SARS-CoV-2 entry pathways on entry assays that then drive our understanding of humoral immunity, therapeutic efficacy, and tissue restriction. We focus especially on the proteolytic activation of SARS-CoV-2 spike and how this constellation of proteases lends deeper insight to our understanding of arising variants and their putative role transmission or variable pathogenicity in vivo. In this review, we argue for better universal standards to assay virus entry as well as suggest best practices for reporting viral passage number, the cell line used, and proteases present, among other important considerations.
. 2021 Jul 24;50:49-58.
doi: 10.1016/j.coviro.2021.07.004. Online ahead of print.
Proteases and variants: context matters for SARS-CoV-2 entry assays
Christian S Stevens[SUP] 1 [/SUP], Kasopefoluwa Y Oguntuyo[SUP] 1 [/SUP], Benhur Lee[SUP] 2 [/SUP]
Affiliations
- PMID: 34365113
- DOI: 10.1016/j.coviro.2021.07.004
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), like other coronaviruses, relies on a flexible array of entry mechanisms, driven by the spike (S) protein. Entry is dependent on proteolytic priming, activation, and receptor binding; all of which can be variable, dependent on context. Here we review the implications of the complexity of SARS-CoV-2 entry pathways on entry assays that then drive our understanding of humoral immunity, therapeutic efficacy, and tissue restriction. We focus especially on the proteolytic activation of SARS-CoV-2 spike and how this constellation of proteases lends deeper insight to our understanding of arising variants and their putative role transmission or variable pathogenicity in vivo. In this review, we argue for better universal standards to assay virus entry as well as suggest best practices for reporting viral passage number, the cell line used, and proteases present, among other important considerations.